Serum iron and ferritin in acute neuroleptic akathisia

Psychiatry Research

Volumn 93, Issue 3, 2000, Pages 201-207

  Hofmann, Marc ^a   Seifritz, Erich ^a   Botschev, Claudia ^b   Kräuchi, Kurt ^a   Müller Spahn, Franz ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antipsychotics; Extrapyramidal side effects; Neuroleptics; Schizophrenia

Indexed keywords

BENPERIDOL; BROMPERIDOL; BUTYROPHENONE DERIVATIVE; CLOPENTHIXOL DECANOATE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; PERAZINE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; TRIFLUOPERAZINE;

ADULT; AKATHISIA; ARTICLE; CATATONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANIA; PANIC; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA;

ADULT; AKATHISIA, DRUG-INDUCED; ANEMIA, IRON-DEFICIENCY; ANTIPSYCHOTIC AGENTS; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 0034630411     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00115-3     Document Type: Article

References (27)

1. Barclay C.L., Lang A.E. Withdrawa akathisia. Movement Disorders. 3:1992;296-302.
2. Barnes T.R., Halstead S.M., Little P.W. Relationship between iron status and chronic akathisia in an inpatient population with chronic schizophrenia. British Journal of Psychiatry. 161:1992;791-796.
3. Barton A., Bowie J., Ebmeier K. Low plasma iron status and akathisia. Journal of Neurology, Neurosurgery and Psychiatry. 53:1990;671-674.
4. Braude W.M., Barnes T.R., Gore S.M. Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. British Journal of Psychiatry. 143:1983;139-150.
5. Brown K.W., Glen S.E., Whithe T. Low serum iron status and akathisia. Lancet. 1:1987;1234-1236.
6. Fleischhacker W.W., Bergmann K.J., Perovich R., Pestreich L.K., Borenstein M., Lieberman J.A., Kane J.M. The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia. Psychopharmacology Bulletin. 25:1989;222-226.
7. Fleischhacker W.W., Milller C., Schett P. The Hillside Akathisia Scale: a reliability comparison of the English and German versions. Psychopharmacology. 105:1991;141-144.
8. Fornazzari L., Remington G., Jeffries J. Akathisia, porphyria and low iron [letter]. Canadian Journal of Psychiatry. 36:1991;548.
9. Gelenberg A.J. Antipsychotic drugs. Bassuk E.L., Schooner S.C., Gelenberg A.J. The Practioner's Guide to Psychoactive Drugs, 2nd ed. 1983;124 Plenum Medical Book Company, New York.
10. Gold R., Lenox R.H. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. Journal of Clinical Psychiatry. 56:1995;476-483.
11. Horiguchi J. Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment. Acta Psychiatrica Scandinavica. 84:1991;301-303.
12. Marsden C., Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psycholgical Medicine. 10:1980;55-72.
13. Miller C.H., Hummer M., Oberbauer H., Kurzthaler I., DeCol C., Fleischhacker W.W. Risk factors for the development of neuroleptic induced akathisia. European Neuropsychopharmacology. 7:1997;51-55.
14. Nemes Z.C., Rotrosen J., Angrist B., Peslow E., Schoentag R. Serum iron levels and akathisia. Biological Psychiatry. 29:1992;411-413.
15. O'Loughlin V., Dickie A.C., Ebmeier K.P. Serum iron and transferrin in acute neuroleptic induced akathisia. Journal of Neurology, Neurosurgery and Psychiatry. 54:1991;363-364.
16. Sachdev P. Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal. Psychopharmacology. 114:1994;181-186.
17. Sachdev P. The epidemiology of drug-induced akathisia: Part I. Acute akathisia. Schizophrenia Bulletin. 21:1995;431-449.
18. Sachdev P. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias. Schizophrenia Bulletin. 21:1995;451-461.
19. Sachdev P., Lonergan C. Acute drug-induced akathisia is not associated with low serum iron status. Psychopharmacology. 103:1991;138-139.
20. Sachdev P., Lonergan C. The present status of akathisia. Journal of Nervous and Mental Disease. 179:1991;381-391.
21. Schmidt L.G., Grohamann R., Helmchen H. Adverse drug reactions. Acta Psychiatrica Scandinavica. 70:1984;77-89.
22. Valles V., Guillamat R., Vilaplana C., Duno R., Almenar C. Serum iron and akathisia. Biological Psychiatry. 31:1992;1174-1175.
23. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry. 31:1974;67-72.
24. Wick M., Pinggera W., Lehmann P. Ferritin im Eisenstoffwechsel, Diagnostische Strategien. 1991;Springer-Verlag, Wien.
25. Wirshing D.A., Bartzokis G., Pierre J.M., Wirshing W.C., Sun A., Tishler T.A., Marder S.R. Tardive dyskinesia and serum iron indices. Biological Psychiatry. 44:1998;493-498.
26. Youdim M. Brain iron metabolism: biochemical and behavioural aspects in relation to dopaminergic transmission. Lajtha A. Handbook of Neurochemistry, vol 10., 2nd ed. 1985;731-756 Plenum Press, New York, NY.
27. Youdim M., Yehuda S., Ben-Shachar D. Behavioral and brain biochemical changes in iron-deficient rats: the involvement of iron in dopamine receptor function. Pollitt E., Leibel R. Iron Deficiency: Brain Biochemistry and Behaviour. 1982;Raven, New York.